Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms

Cancer

Volumn 89, Issue 4, 2000, Pages 733-740

  Mikami, Tetuo ^a   Mitomi, Hiroyuki ^a   Hara, Atsuko ^a   Yanagisawa, Nobuyuki ^a   Yoshida, Tsutomu ^a   Tsuruta, Osamu ^b   Okayasu, Isao ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cadherin; Catenin; CD44; Cell adhesion molecule; Deleted colon carcinoma (DCC); Ulcerative colitis associated carcinoma

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CELL ADHESION MOLECULE; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; COLON CARCINOMA; DISEASE ASSOCIATION; DYSPLASIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ULCERATIVE COLITIS;

EID: 0034663317     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000815)89:4<733::aid-cncr3>3.0.co;2-%23     Document Type: Article

References (30)

1. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms
2. Molecular genetics of dysplasia in ulcerative colitis
3. Adhesion molecules and tumor metastasis
4. CD44 and the adhesion of neoplastic cells
5. CD44 isoform expression follows two alternative splicing pathways in breast tissue
6. Down-regulation of CD44 standard and variant isoforms during the development and progression of uterine cervical tumours
7. E-cadherin mediated adhesion system in cancer cells
8. DCC: Is there a connection between tumorigenesis and cell guidance molecules?
9. Dysplasia in inflammatory bowel disease: Standard classification with provisional clinical applications
10. Bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis
11. p53 Protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma
12. Loss of immunohistochemical E-cadherin expression in colon cancer is not due to structural gene alterations
13. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations
14. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer
15. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation
16. Mutation of alpha-catenin results in invasiveness of human HCT-8 colon cancer cells
17. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression
18. Expression of CD44v6 is associated with cellular dysplasia in colorectal epithelial cells
19. Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer
20. Expression of variant CD44-messenger RNA in colorectal adenocarcinomas and adenomatous polyps in humans
21. CD44V6 expression in human colorectal carcinoma
22. Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma
23. Immunohistochemical detection of alpha-catenin expression in human cancers
24. Beta-catenin expression in human cancers
25. Genetic alterations during colorectal-tumor development
26. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
27. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
28. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway